Literature DB >> 27353494

Heterologous expression of Cenchritis muricatus protease inhibitor II (CmPI-II) in Pichia pastoris system: Purification, isotopic labeling and preliminary characterization.

Aymara Cabrera-Muñoz1, Laritza Rojas2, Dayrom F Gil3, Yamile González-González4, Manuel Mansur5, Ayamey Camejo6, José R Pires7, Maday Alonso-Del-Rivero Antigua8.   

Abstract

Cenchritis muricatus protease inhibitor II (CmPI-II) is a tight-binding serine protease inhibitor of the Kazal family with an atypical broad specificity, being active against several proteases such as bovine pancreatic trypsin, human neutrophil elastase and subtilisin A. CmPI-II 3D structures are necessary for understanding the molecular basis of its activity. In the present work, we describe an efficient and straightforward recombinant expression strategy, as well as a cost-effective procedure for isotope labeling for NMR structure determination purposes. The vector pCM101 containing the CmPI-II gene, under the control of Pichia pastoris AOX1 promoter was constructed. Methylotrophic Pichia pastoris strain KM71H was then transformed with the plasmid and the recombinant protein (rCmPI-II) was expressed in benchtop fermenter in unlabeled or (15)N-labeled forms using ammonium chloride ((15)N, 99%) as the sole nitrogen source. Protein purification was accomplished by sequential cation exchange chromatography in STREAMLINE DirectHST, anion exchange chromatography on Hitrap Q-Sepharose FF and gel filtration on Superdex 75 10/30, yielding high quantities of pure rCmPI-II and (15)N rCmPI-II. Recombinant proteins displayed similar functional features as compared to the natural inhibitor and NMR spectra indicated folded and homogeneously labeled samples, suitable for further studies of structure and protease-inhibitor interactions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Isotopic labeling; NMR; Pichia pastoris; Recombinant expression; Serine protease inhibitor

Mesh:

Substances:

Year:  2016        PMID: 27353494     DOI: 10.1016/j.pep.2016.06.011

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  1 in total

1.  Recombinant Inga Laurina Trypsin Inhibitor (ILTI) Production in Komagataella Phaffii Confirms Its Potential Anti-Biofilm Effect and Reveals an Anti-Tumoral Activity.

Authors:  Fábio C Carneiro; Simone S Weber; Osmar N Silva; Ana Cristina Jacobowski; Marcelo H S Ramada; Maria L R Macedo; Octávio L Franco; Nádia S Parachin
Journal:  Microorganisms       Date:  2018-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.